This new book summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone and venlafaxine in treating patients with MDD, dysthymia and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia or neurovegetative symptoms..
Cumpărați această carte electronică și primiți încă 1 GRATUIT!
Format PDF ● Pagini 475 ● ISBN 9781536115543 ● Editor Diane C Wimmer ● Editura Nova Science Publishers ● Publicat 2017 ● Descărcabil 3 ori ● Valută EUR ● ID 7216850 ● Protecție împotriva copiilor Adobe DRM
Necesită un cititor de ebook capabil de DRM